“Successful Utilization of the GLP-1 Receptor Agonist Semaglutide in Treating the Manifestations of Recalcitrant Celiac Disease”. 2025. Archives of Clinical and Biomedical Research 9 (5): 392-95. https://fortunejournals.org/ojs/index.php/acbr/article/view/15136.